The secret life of Antimicrobial peptides
When it comes to
the immune system, we usually think about lymphocytes B and T cells or
macrophages going on constant seek-and-destroy missions against invading
pathogens like bacteria and viruses. But our immune system actually includes a
lesser-known and less-studied first line of defence referred to as "innate immunity."
One of the main weapons of innate immunity is a family of
small peptides, collectively known as "antimicrobial
peptides" or AMPs for short. AMPs are produced by the host's (e.g. the
human's) cells and combat invading microorganisms by breaking apart their cell
membranes or by disrupting their functions.
Despite of their importance, we know very little about
AMPs. Some in vitro studies have
shown that they can kill bacteria and fungi, but scientists have been hard
pressed to study them in living organisms. One of the reasons is that there are
simply too many factors involved in innate immunity, so isolating the effect of
individual AMPs in a living organism is a very complex proposition.
But now we have the tools. Scientists from the lab of
Bruno Lemaitre at EPFL's Global Health Institute have used CRISPR, the
gene-editing technique, to delete no less than 14 AMPs from the fruit fly
Drosophila. By deleting single AMP genes, various combinations of genes, or
even all 14 genes, the scientists were able to remove their corresponding AMPs
and observe how their absence affected the fly's resistance to different
bacterial and fungal pathogens.
The results showed that, at least in Drosophila, AMPs act mainly against Gram-negative bacteria (e.g. E.
coli, Enterobacter species) and certain fungi. The AMPs also work either
together or by adding up their individual effects. Surprisingly, they found
that certain AMPs can be incredibly specific in defending against certain
infections (e.g. the AMP diptericin against the pathogen P. rettgeri). This
unexpected result highlights a previously unknown level of specificity to the
innate immune response.
"What's really exciting is that these results will
help us understand how our own AMPs might help fight infection," says Mark
Austin Hanson, the study's first author. "It could be that some people
have a defective copy of a specific AMP needed to prevent a common infection --
as an example, uropathogenic E. coli -- and so they are at higher risk.
Fighting infection is great, but learning how to prevent it in the first place
is the ideal of medicine. That's what these AMPs do: they prevent infection
before it ever settles in."
But the applications of studying AMPs go even further,
Hanson adds. "Studying how the fly's AMPs work can also help us manage
economically important insects, whether it be protecting bumblebees or
preventing mosquitoes from spreading disease."
Comments
Post a Comment